This article is more than 5 years old. Information may no longer be current.

Urologic oncologist joins UCLA faculty

Issue: June 10, 2014

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Stuart Holden, MD, has been named associate director of the UCLA Institute of Urologic Oncology.

Holden, a urologic oncologist and surgeon, also will serve as a health sciences clinical professor in the department of urology at the David Geffen School of Medicine at UCLA.

Holden previously served as director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai Medical Center. He was a founding partner at Tower Urology in Los Angeles, and he has served as medical director of the Prostate Cancer Foundation since its inception in 1993.

 

Stuart Holden

“We are thrilled to have recruited Dr. Holden to join UCLA Urology,” Mark S. Litwin, MD, professor and chair of the UCLA Department of Urology, said in a press release. “For more than 50 years, our mission has been to deliver compassionate, high-quality patient care through innovative research and specialized urologic programs. It is an honor to have Dr. Holden fortify our team with his extensive urologic oncology expertise.”